3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
14
Sarcoma
3
Lymphoid
2
Gastrointestinal
2
Genitourinary
1
Dermatologic
1
Conditions
Prostatic Neoplasms
504
Carcinoma, Renal Cell
166
Urinary Bladder Neoplasms
136
Carcinoma, Transitional Cell
71
Carcinoma, Non-Small-Cell Lung
58
Kidney Neoplasms
55
Melanoma
54
Breast Neoplasms
51
Ovarian Neoplasms
43
Neoplasms
41
Neoplasm Metastasis
40
Colorectal Neoplasms
39
Lung Neoplasms
27
Squamous Cell Carcinoma of Head and Neck
26
Uterine Cervical Neoplasms
25
Stomach Neoplasms
25
Sarcoma
25
Non-Muscle Invasive Bladder Neoplasms
25
Endometrial Neoplasms
24
Triple Negative Breast Neoplasms
21
Pancreatic Neoplasms
19
Wilms Tumor
18
Esophageal Neoplasms
18
Carcinoma, Hepatocellular
17
Head and Neck Neoplasms
16
Small Cell Lung Carcinoma
15
Colonic Neoplasms
15
Urologic Neoplasms
14
Urethral Neoplasms
13
Ureteral Neoplasms
13
Interventions
CLR1404
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Diffuse Intrinsic Pontine Glioma
×
Genitourinary
×
Clear all
NCT03478462
2026-03-18
CLOVER-2
Cellectar Biosciences, Inc.
Phase 1
Active not recruiting
30 enrolled